Cite
APA Citation
Heidenreich, R., Mehr, K. T., Noth, J., Koch, S., Hong, H., Melber, K., Daehling, A., Roos, T., Lutz, J., Kowalczyk, A., Baumhof, P., Scheel, B., Voss, S., Kallen, K., Fotin-Mleczek, M., & Gnad-Vogt, U. (n.d.). rNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile. Journal for immunotherapy of cancer, 3, . http://access.bl.uk/ark:/81055/vdc_100137791952.0x000004